Inhibitory Role of Notch1 in Calcific Aortic Valve Disease
暂无分享,去创建一个
H. Garner | R. Hinton | V. Garg | C. Galindo | A. Acharya | S. Koenig | W. Merrill | C. Hans | Haley A. Nichols
[1] Javier Bermejo,et al. Diet-Induced Aortic Valve Disease in Mice Haploinsufficient for the Notch Pathway Effector RBPJK/CSL , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[2] K. McBride,et al. Heredity of bicuspid aortic valve: is family screening indicated? , 2011, Heart.
[3] R. Hinton,et al. Differential expression of cartilage and bone-related proteins in pediatric and adult diseased aortic valves. , 2011, Journal of molecular and cellular cardiology.
[4] D. Mozaffarian,et al. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. , 2011, Circulation.
[5] M. Zenke,et al. Activated Notch1 Target Genes during Embryonic Cell Differentiation Depend on the Cellular Context and Include Lineage Determinants and Inhibitors , 2010, PloS one.
[6] J. Lincoln,et al. Reduced Sox9 Function Promotes Heart Valve Calcification Phenotypes In Vivo , 2010, Circulation Research.
[7] D. Srivastava,et al. Notch1 represses osteogenic pathways in aortic valve cells. , 2009, Journal of molecular and cellular cardiology.
[8] K. Yutzey,et al. Notch pathway regulation of chondrocyte differentiation and proliferation during appendicular and axial skeleton development , 2009, Proceedings of the National Academy of Sciences.
[9] Raphael Kopan,et al. The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism , 2009, Cell.
[10] Holger Gerhardt,et al. Angiogenesis: a team effort coordinated by notch. , 2009, Developmental cell.
[11] Frederick J. Schoen,et al. Evolving Concepts of Cardiac Valve Dynamics: The Continuum of Development, Functional Structure, Pathobiology, and Tissue Engineering , 2008, Circulation.
[12] Qiuhui Pan,et al. Sox9, a key transcription factor of bone morphogenetic protein‐2‐induced chondrogenesis, is activated through BMP pathway and a CCAAT box in the proximal promoter , 2008, Journal of cellular physiology.
[13] Brendan H. Lee,et al. Dimorphic effects of Notch signaling in bone homeostasis , 2008, Nature Medicine.
[14] Tatsuya Kobayashi,et al. Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation , 2008, Nature Medicine.
[15] T. Sundt,et al. Novel NOTCH1 mutations in patients with bicuspid aortic valve disease and thoracic aortic aneurysms. , 2007, The Journal of thoracic and cardiovascular surgery.
[16] R. Bonow,et al. Calcific aortic stenosis: an update , 2007, Nature Clinical Practice Cardiovascular Medicine.
[17] R. Kist,et al. Sox9 is required for precursor cell expansion and extracellular matrix organization during mouse heart valve development. , 2007, Developmental biology.
[18] C. Steidl,et al. Combined Loss of Hey1 and HeyL Causes Congenital Heart Defects Because of Impaired Epithelial to Mesenchymal Transition , 2007, Circulation research.
[19] Shinsuke Yuasa,et al. Chondromodulin-I maintains cardiac valvular function by preventing angiogenesis , 2006, Nature Medicine.
[20] J. Gardin,et al. Burden of valvular heart diseases: a population-based study , 2006, The Lancet.
[21] J. Erdmann,et al. Novel missense mutations (p.T596M and p.P1797H) in NOTCH1 in patients with bicuspid aortic valve. , 2006, Biochemical and biophysical research communications.
[22] K. Yutzey,et al. Hearts and bones: shared regulatory mechanisms in heart valve, cartilage, tendon, and bone development. , 2006, Developmental biology.
[23] R. Hinton,et al. Extracellular Matrix Remodeling and Organization in Developing and Diseased Aortic Valves , 2006, Circulation research.
[24] V. Garg,et al. Molecular genetics of aortic valve disease , 2006, Current opinion in cardiology.
[25] D. Srivastava,et al. Mutations in NOTCH1 cause aortic valve disease , 2005, Nature.
[26] R. Norris,et al. Normal distribution of melanocytes in the mouse heart. , 2005, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.
[27] Rosario V. Freeman,et al. Spectrum of Calcific Aortic Valve Disease: Pathogenesis, Disease Progression, and Treatment Strategies , 2005, Circulation.
[28] W. Edwards,et al. Calcified Rheumatic Valve Neoangiogenesis Is Associated With Vascular Endothelial Growth Factor Expression and Osteoblast-Like Bone Formation , 2005, Circulation.
[29] F. Dagenais,et al. Calcification of human valve interstitial cells is dependent on alkaline phosphatase activity. , 2005, The Journal of heart valve disease.
[30] Kozo Nakamura,et al. The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. , 2004, Arthritis and rheumatism.
[31] Joyce Bischoff,et al. Heart valve development: endothelial cell signaling and differentiation. , 2004, Circulation research.
[32] J. Epstein,et al. Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[33] David C. Lee,et al. Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling , 2003, Journal of Molecular Medicine.
[34] P. Libby,et al. Activated Interstitial Myofibroblasts Express Catabolic Enzymes and Mediate Matrix Remodeling in Myxomatous Heart Valves , 2001, Circulation.
[35] D. Srivastava,et al. Members of the HRT family of basic helix-loop-helix proteins act as transcriptional repressors downstream of Notch signaling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[36] V. Lefebvre,et al. Transcriptional mechanisms of chondrocyte differentiation. , 2000, Matrix biology : journal of the International Society for Matrix Biology.
[37] J. Richardson,et al. Microsomal triglyceride transfer protein expression during mouse development. , 2000, Journal of lipid research.
[38] S. Akhtar,et al. Ultrastructure abnormalities in proteoglycans, collagen fibrils, and elastic fibers in normal and myxomatous mitral valve chordae tendineae. , 1999, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[39] R. Levy,et al. Identification and characterization of calcifying valve cells from human and canine aortic valves. , 1999, The Journal of heart valve disease.
[40] Richard R. Behringer,et al. Sox9 is required for cartilage formation , 1999, Nature Genetics.
[41] N. Fujiwara,et al. Histochemical and immunohistochemical analysis of the mechanism of calcification of Meckel's cartilage during mandible development in rodents , 1999, Journal of anatomy.
[42] P N Goodfellow,et al. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene , 1997, Molecular and cellular biology.
[43] M. Thubrikar,et al. Patterns of calcific deposits in operatively excised stenotic or purely regurgitant aortic valves and their relation to mechanical stress. , 1986, The American journal of cardiology.
[44] Frank McCormick,et al. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. , 2004, Genes & development.